NCT04212481

RCT of Uniport VATS for Lung Cancer

Randomized Controlled Trial of the Comparison of Uniport VATS and Non- Uniport VATS for Lung Cancer

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 300 (estimated)
• Sponsor: The Second Hospital of Shandong University · Academic / Other
• Sex: All
• Age: 25 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Video-assisted thoracoscopic surgery (VATS) has been widely used for non-small cell lung cancer (NSCLC) for nearly two decades. Usually, it was applied through three ports with at least one drainage after surgery, which often lead to acute chest pain. Therefore, fewer, smaller ports, and wider intercostal space for surgery has been required. Uniport VATS became a feasible option with the development of surgical techniques and instruments, with potentially less postoperative pain and shorter hospital stays. However, there may be some complications, or with a longer time of operation, even more difficult in lymph nodes resection during learning curve. In our study, a Randomized Controlled Trial was designed to study the operation time, perioperative blood loss, conversion rate, duration of postoperative drainage, length of hospital stay, visual analogue score of postoperative pain, complications, and survival.

Conditions

• Single-port Video-assisted Thoracoscopic Surgery

Interventions

Type	Name	Description
PROCEDURE	uniport video-assisted thoracoscopic surgery	video-assisted thoracoscopic surgery for NSCLC using single port or two ports or three ports
PROCEDURE	two ports video-assisted thoracoscopic surgery	video-assisted thoracoscopic surgery for NSCLC using two ports
PROCEDURE	three ports video-assisted thoracoscopic surgery	video-assisted thoracoscopic surgery for NSCLC using three ports

Timeline

• Start date: 2019-12-25
• Primary completion: 2022-12-30
• Completion: 2025-12-30
• First posted: 2019-12-27
• Last updated: 2022-11-16

Locations

1 site across 1 country: China